[89Zr]9H10 quantification in tumor tissue
| Injected (enestic) tumor | Contralateral (anenestic) tumor | ||||
| Treatment group | Antibody quantity at day 7 (µg) | Percentage of injected dose | Antibody quantity at day 7 (µg) | Percentage of dose in enestic tumor | Percentage of injected dose |
| 20 µg | 1.48 (±0.32) | 7.4 (±1.6) | 0.11 (±0.07) | 7.4 (±4.7) | 0.55 (±0.35) |
| 100 µg | 6.27 (±0.85) | 6.3 (±0.85) | 0.51 (±0.25) | 8.1 (±4.0) | 0.51 (±0.25) |
| 200 µg | 11.78 (±2.05) | 5.9 (±1.0) | 1.42 (±1.11) | 12.1 (±9.4) | 0.71 (±0.55) |
Data are presented as mean±SD.
[89Zr], zirconium-89.